Given the role of NIK in promoting pro-inflammatory gene expression and supporting tumor cell survival, the inhibition of NIK has become a significant focus for the development of therapeutic strategies aimed at mitigating these harmful effects. This evidence concerns the gene MAP3K14 and neoplasm.